Pyruvate dehydrogenase is a potential mitochondrial off-target for gentamicin based on in silico predictions and in vitro inhibition studies

In conclusion, the use of in silico methods appeared a valuable approach in predicting PDH as a mitochondrial off-target of gentamicin. Further research is required to investigate the contribution of PDH inhibition to overall renal toxicity of gentamicin.PMID:38036072 | DOI:10.1016/j.tiv.2023.105740
Source: Toxicology in Vitro - Category: Toxicology Authors: Source Type: research
More News: Chemistry | Study | Toxicology | Viread